We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Colombia Harmonizes Vaccine Regulations, Clarifies Preclinical, Clinical Requirements
Companies seeking to market vaccines in Colombia must provide the drug regulatory authority with the results of Phase IV studies, details of each study’s protocol and a complete pharmacovigilance plan, new technical information released by INVIMA says.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor